A randomized, double blind, placebo-controlled study to investigate the effect of E2007 [perampanel] on pharmacodynamic responses to levodopa among patients with Parkinson's disease who experience dyskinesia and motor fluctuations

Trial Profile

A randomized, double blind, placebo-controlled study to investigate the effect of E2007 [perampanel] on pharmacodynamic responses to levodopa among patients with Parkinson's disease who experience dyskinesia and motor fluctuations

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2013

At a glance

  • Drugs Levodopa; Perampanel
  • Indications Parkinson's disease
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 10 Sep 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 29 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top